SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-022194
Filing Date
2024-05-09
Accepted
2024-05-09 16:04:01
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sgmo-20240331.htm   iXBRL 10-Q 915453
2 EX-10.1 secondamendmenttoleaseag.htm EX-10.1 17866
3 EX-31.1 sgmo-20240331xex311.htm EX-31.1 10017
4 EX-31.2 sgmo-20240331xex312.htm EX-31.2 10132
5 EX-32.1 sgmo-20240331xex321.htm EX-32.1 7126
11 GRAPHIC secondamendmenttoleaseag001.jpg GRAPHIC 244063
12 GRAPHIC secondamendmenttoleaseag002.jpg GRAPHIC 311423
13 GRAPHIC secondamendmenttoleaseag003.jpg GRAPHIC 316673
14 GRAPHIC secondamendmenttoleaseag004.jpg GRAPHIC 262478
15 GRAPHIC secondamendmenttoleaseag005.jpg GRAPHIC 84834
16 GRAPHIC secondamendmenttoleaseag006.jpg GRAPHIC 58043
  Complete submission text file 0001628280-24-022194.txt   7093284

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20240331.xsd EX-101.SCH 40460
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20240331_cal.xml EX-101.CAL 58367
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20240331_def.xml EX-101.DEF 214978
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20240331_lab.xml EX-101.LAB 437857
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20240331_pre.xml EX-101.PRE 320325
71 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20240331_htm.xml XML 720865
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 24930361
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)